Literature DB >> 19167210

Cancer stem cells: a model in the making.

Lauren L Campbell Marotta1, Kornelia Polyak.   

Abstract

Cancer stem cells and their potential roles in tumor heterogeneity are currently subjects of intense investigation. Studies suggest that these cells may develop from any normal cell and have begun to elucidate their molecular profiles. The percentage of a tumor composed of cancer stem cells varies greatly, and researchers believe that multiple types of these cells may exist in a single neoplasm. Cancer stem cells may be formed by epithelial-mesenchymal transition and seem to be less prevalent in metastases than in corresponding primary tumors. These cells appear to have therapeutic sensitivities different from those of cancer cells with more differentiated features. Looking into the many questions that remain about the cancer stem cells model might lead to more effective cancer prevention, diagnosis, and treatment.

Entities:  

Mesh:

Year:  2009        PMID: 19167210     DOI: 10.1016/j.gde.2008.12.003

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  53 in total

1.  Tumor-initiating cells and treatment resistance: how goes the war?

Authors:  Michael T Lewis; Max S Wicha
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-02-24       Impact factor: 2.673

2.  The role of stromal factors in breast tumorigenicity.

Authors:  Danh Tran-Thanh; Susan J Done
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

Review 3.  Preinvasive breast cancer.

Authors:  Dennis C Sgroi
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

4.  Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion.

Authors:  Dimitrios Iliopoulos; Heather A Hirsch; Guannan Wang; Kevin Struhl
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

5.  Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cells.

Authors:  Yu-I Weng; Pei-Yin Hsu; Sandya Liyanarachchi; Joseph Liu; Daniel E Deatherage; Yi-Wen Huang; Tao Zuo; Benjamin Rodriguez; Ching-Hung Lin; Ann-Lii Cheng; Tim H-M Huang
Journal:  Toxicol Appl Pharmacol       Date:  2010-08-01       Impact factor: 4.219

6.  An integrated transcriptional regulatory circuit that reinforces the breast cancer stem cell state.

Authors:  Christos Polytarchou; Dimitrios Iliopoulos; Kevin Struhl
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

Review 7.  Stem cell paracrine actions and tissue regeneration.

Authors:  Priya R Baraniak; Todd C McDevitt
Journal:  Regen Med       Date:  2010-01       Impact factor: 3.806

8.  HepG2 cells acquire stem cell-like characteristics after immune cell stimulation.

Authors:  Hang Wang; Miqing Yang; Ling Lin; Hongzhen Ren; Chaotong Lin; Suling Lin; Guoying Shen; Binfeng Ji; Chun Meng
Journal:  Cell Oncol (Dordr)       Date:  2015-12-09       Impact factor: 6.730

9.  Role of chemokine network in the development and progression of ovarian cancer: a potential novel pharmacological target.

Authors:  Federica Barbieri; Adriana Bajetto; Tullio Florio
Journal:  J Oncol       Date:  2009-12-14       Impact factor: 4.375

10.  The 'stem cell' concept: is it holding us back?

Authors:  Arthur D Lander
Journal:  J Biol       Date:  2009-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.